• Adventa’s 4Q16 net profit tumbled 81.4% to RM141,000, mainly due to higher operating and marketing expenditure for the home dialysis services business.
  • This was despite its revenue for the quarter rising 5.2% to RM10.6 million.
  • For the full year, the group’s net profit slid 78.3% to RM670,000, on the back of a 4.7% decline in revenue to RM39.9 million.
  • Hong Leong IB Research has maintained its ‘Hold’ rating on Adventa, with a lower target price of RM0.66.

Significance: Hong Leong IB Research commented that going forward, it expects Adventa to be subjected to higher operating expenses and margin pressures, due to the weaker ringgit.

Get weekly updates from us

Build your wealth. Start now.

Enjoying our content? You might want to subscribe to our weekly newsletter.
Hand-picked content and wealth-building resources for you.

You May Also Like

Editor's Picks